- Home
- BNT vs SNN Comparison
BNT vs SNN Comparison
Compare BNT & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNT
- SNN
- Stock Information
- Founded
- BNT 2020
- SNN 1856
- Country
- BNT Bermuda
- SNN United Kingdom
- Employees
- BNT N/A
- SNN N/A
- Industry
- BNT
- SNN Industrial Specialties
- Sector
- BNT
- SNN Health Care
- Exchange
- BNT Nasdaq
- SNN Nasdaq
- Market Cap
- BNT 15.0B
- SNN 13.2B
- IPO Year
- BNT N/A
- SNN 1999
- Fundamental
- Price
- BNT $65.56
- SNN $37.25
- Analyst Decision
- BNT
- SNN Hold
- Analyst Count
- BNT 0
- SNN 3
- Target Price
- BNT N/A
- SNN $31.50
- AVG Volume (30 Days)
- BNT 8.0K
- SNN 961.3K
- Earning Date
- BNT 08-07-2025
- SNN 10-30-2025
- Dividend Yield
- BNT 0.55%
- SNN 1.96%
- EPS Growth
- BNT N/A
- SNN 59.91
- EPS
- BNT 2.78
- SNN 0.56
- Revenue
- BNT $14,371,000,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- BNT N/A
- SNN $7.75
- Revenue Next Year
- BNT N/A
- SNN $5.37
- P/E Ratio
- BNT $23.50
- SNN $66.79
- Revenue Growth
- BNT 57.06
- SNN 5.35
- 52 Week Low
- BNT $43.69
- SNN $23.69
- 52 Week High
- BNT $68.87
- SNN $37.65
- Technical
- Relative Strength Index (RSI)
- BNT 52.17
- SNN 70.43
- Support Level
- BNT $63.07
- SNN $37.02
- Resistance Level
- BNT $66.02
- SNN $37.65
- Average True Range (ATR)
- BNT 0.82
- SNN 0.37
- MACD
- BNT -0.15
- SNN -0.05
- Stochastic Oscillator
- BNT 76.62
- SNN 79.17
About BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.